27 results
8-K
EX-10.1
NRBO
NeuroBo Pharmaceuticals Inc
22 Dec 22
Departure of Directors or Certain Officers
5:08pm
, with the balance paid thereafter on the original schedule.
(o) Choice of Law. This Plan and any controversy arising out of or relating to this Plan
424B5
xk2bl9n9k4
4 Oct 21
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.2
3rvp2em wspc15
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-2.1
6ggyo1 c3q6tmsf6b9zq
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
424B5
yb2 hiw2jt3
15 Apr 20
Prospectus supplement for primary offering
5:19pm
424B3
chh jasbhauy0d
6 Nov 19
Prospectus supplement
9:15am
S-4/A
le8ek1fl xz
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4/A
EX-10.35
mvypk9fv
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
28xzwq1s6qpnbb 9zq5
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
8-K
EX-2.3
q4jvmqdj
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am